Reported Reactions

Devices › Device types

FDA product code LTI · class 3 · Unknown

Implant, intragastric for morbid obesity: medical device reports filed with FDA

17,678 reports carry this product code, 1994–2026; 19 brands with a page.

17,678
reports with this product code
0.1% of all MAUDE reports
204
reports, 12 months to August 2026
334 in the 12 months before
60.3%
classified as malfunction
62.3% across all reports
1.1%
classified as death, as reported
0.9% across all reports

Product code LTI is FDA's classification for "Implant, intragastric for morbid obesity" (unknown panel), a class 3 device. 17,678 medical device reports carry this product code, 0.1% of the MAUDE database, from June 1994 to August 2026.

204 reports arrived in the 12 months to August 2026, down 39% from 334 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (60.3%), injury (38.1%) and death (1.1%). 19 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Lap-Band Adjustable Gastric Banding System2,17402%69.3%
Lap-Band Adjustable Gastric Banding System Unk Size1,78102%51.2%
Lap-Band Adjustable Gastric Banding System 9 75cm1,48800.1%84.8%
Lap-Band System1,35702%23.4%
Lap-Band Adjustable Gastric Banding System 10 0cm1,18400.4%71.3%
Spatz3 Adjustable Balloon System9061250.6%93.3%
Orbera Intragastric Balloon System827102.5%62.8%
Lap-Band Ap Adjustable Gastric Banding System Standard80100.4%48.8%
Realize Adj Gastric Band Str52700.2%34.2%
Realize Adj Gastric Band-C52400%60.1%
Lap-Band Adjustable Gastric Banding System Vg48900.8%68.4%
Lap-Band Ap Adjustable Gastric Banding System Small44801.1%46.2%
Lap-Band Ap Adjustable Gastric Banding System Large43701.1%62%
ORBERA365 Intragastric Balloon System350290.3%77.4%
Sagb Quickclose With Velocity Injection Port24500%36.7%
Gen2 Adjustable Gastric Band - 11 Cm Unlocka19600.5%70.9%
Orbera Intragastric Balloon15901.3%35.8%
Sagb Quick Close15800%26.6%
Adante Catheter100.5%87.4%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Allergan5,13629.1%
Bioenterics3,29818.7%
Apollo Endosurgery2,22612.6%
Obtech Medical Sarl1,82610.3%
Reshape Lifesciences1,1216.3%
Allergan Costa Rica1821%
Ethicon Endo-Surgery680.4%
Ethicon Endo Surgery70%
Boston Scientific Ireland10%
Cordis Europa10%

Reports by month, five years

077154Sep 2021: 11Oct 2021: 20Nov 2021: 10Dec 2021: 332022Jan 2022: 39Feb 2022: 49Mar 2022: 27Apr 2022: 24May 2022: 38Jun 2022: 53Jul 2022: 57Aug 2022: 58Sep 2022: 60Oct 2022: 50Nov 2022: 91Dec 2022: 632023Jan 2023: 36Feb 2023: 90Mar 2023: 154Apr 2023: 125May 2023: 116Jun 2023: 71Jul 2023: 39Aug 2023: 119Sep 2023: 79Oct 2023: 45Nov 2023: 45Dec 2023: 562024Jan 2024: 49Feb 2024: 53Mar 2024: 78Apr 2024: 24May 2024: 28Jun 2024: 36Jul 2024: 21Aug 2024: 36Sep 2024: 25Oct 2024: 21Nov 2024: 54Dec 2024: 262025Jan 2025: 16Feb 2025: 37Mar 2025: 49Apr 2025: 13May 2025: 26Jun 2025: 29Jul 2025: 26Aug 2025: 12Sep 2025: 29Oct 2025: 19Nov 2025: 36Dec 2025: 82026Jan 2026: 11Feb 2026: 19Mar 2026: 9Apr 2026: 25May 2026: 12Jun 2026: 15Jul 2026: 13Aug 2026: 8

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death1.1%191
Injury38.1%6,742
Malfunction60.3%10,655
Other0.1%26
Not given0.4%64

Who filed

Manufacturer report96.2%17,004
Voluntary report2.3%407
User facility report0%0
Distributor report0%0
Not given1.5%267

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Explanted5,24229.7%
Leak/splashthe device leaked4,16423.6%
Fluid/blood leak3,37619.1%
Device slipped1,6289.2%
Insufficient device problem information1,0495.9%
Deflation problem9425.3%
Breakthe device broke7484.2%
Device remains implanted6893.9%
Replace5803.3%
Migration or expulsion of device5323%
Patient-device incompatibilitythe device did not suit the patient4262.4%
Material rupture4252.4%
Port leak(s)3902.2%
Component(s), broken3732.1%
Disconnection3642.1%
Inflation problem2791.6%
Material erosion2341.3%
Unintended deflation2151.2%
Device operates differently than expectedthe device behaved unexpectedly1660.9%
Air/gas in device1650.9%

Questions about implant, intragastric for morbid obesity reports

What is product code LTI?

FDA's classification code for "Implant, intragastric for morbid obesity", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.

How many reports carry this code?

17,678 reports through August 2026, 204 of them in the latest 12 months.

Which brands appear most often?

Lap-Band Adjustable Gastric Banding System (2,174), Lap-Band Adjustable Gastric Banding System Unk Size (1,781), Lap-Band Adjustable Gastric Banding System 9 75cm (1,488), Lap-Band System (1,357) and Lap-Band Adjustable Gastric Banding System 10 0cm (1,184). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.